117890-55-8Relevant articles and documents
METHODS OF MAKING WEE1 INHIBITOR COMPOUNDS
-
Paragraph 0084, (2021/12/31)
The invention relates to a method of producing a WEE1 inhibitor of formula (1A) useful in the treatment of pathological conditions characterized by excessive cell proliferation, such as cancer. In some embodiments, the invention relates to methods for producing intermediate compounds of formulas (3), (5) and (6) as defined in the description.
Method for synthesizing chiral nitrogen-phosphorus ligand L-8 containing pyridocycloheptane
-
, (2021/03/23)
The invention discloses a method for synthesizing a chiral nitrogen-phosphorus ligand L-8 containing pyridocycloheptane, and belongs to the technical field of medical intermediate chiral ligands. Thechiral nitrogen-phosphorus L-8 ligand is prepared from cyclopentanone through the steps of addition, cyclization, chlorination, asymmetric boronation, oxidation, coupling, esterification and the likein sequence, large-scale preparation is relatively easy to achieve through the route, and the defect that in a traditional route, the yield is low in the first step of ring closing reaction and chiralalcohol preparation, and by selecting a proper chiral ligand, and combining with butyl lithium, asymmetric synthesis of chiral alcohol is realized, and a chiral separation column mode adopted in literature is avoided.
Production process of 2,3- cyclopenteno pyridine
-
, (2018/09/08)
2,3-cyclopenteno pyridine has physiological activity of resisting ulcer and resisting cancer, is an important medical intermediate and alkaloid, is also used for preparing plant protective agents, synthetic resin, antioxidants and the like, and is currently used for the side chains of a fourth-generation injection-use aminothiazole cephalosporins, which is cefpirome, and the quantity demanded in developing countries, such as China and India, is growing rapidly at present. The invention provides a production process of the 2,3- cyclopenteno pyridine. The specific process is as follows: (1) preparation of 4,5,6,7-tetrahydro-2-oxo-3-formyl cyclopenteno pyridine, (2) preparation of 2-chloro-2,3-cyclopenteno pyridine, and (3) preparation of the 2,3-cyclopenteno pyridine.